Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Blood Regulatory T Cells in Inflammatory Bowel Disease, a Systematic Review, and Meta-Analysis Publisher Pubmed



Jalalvand M1 ; Enayati S1 ; Akhtari M1, 2 ; Madreseh E1, 2, 3 ; Jamshidi A1 ; Farhadi E1, 2 ; Mahmoudi M1, 2 ; Amirzargar A4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Inflammation Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: International Immunopharmacology Published:2023


Abstract

Introduction: Inflammatory bowel disease (IBD) is an autoimmune disease involving various parts of the gastrointestinal (GI) tract, which includes Crohn's disease (CD) and ulcerative colitis (UC). Due to the contradictory results regarding the percentage of peripheral blood (PB) regulatory T cells (Tregs) in IBD patients, this meta-analysis aimed to determine the Tregs frequency in IBD patients. Method: We searched PubMed, Web of Science, SCOPUS, and Google Scholar databases for relevant observational articles that analyzed and reported the frequency of PB Tregs in IBD patients and healthy control groups. After choosing the related articles by two reviewers, the data regarding the definition of Tregs and their frequencies in different groups were recorded. Result: In 22 studies, the results showed a nonsignificant difference in the frequency of PB Tregs between IBD cases and control subjects (SMD: −0.27, 95 % CI: −0.78, 0.23). However, the frequency of CD4+CD25+CD127− (SMD: −0.89, 95 % CI: −1.52, −0.26) and CD4+CD25+FoxP3+ (SMD: −1.32, 95 % CI: −2.37, −0.26) Tregs were significantly lower in IBD cases, compared to healthy subjects. Also, UC cases and active IBD cases showed a significantly lower frequency of Treg cells, compared to controls and remission IBD cases, respectively (SMD: −0.68, 95 % CI: −1.24, −0.11 and SMD: −0.60, 95 % CI: −0.93, −0.27). Conclusion: Our study highlighted a probable decrease of Tregs in IBD patients, especially the patients with active states of the disease. The decrease of Treg cells might cause an imbalance in the immune system and the over-activation of auto-immune responses against the digestive tract. © 2023
Related Docs
View other Related Docs
1. Altered Microrna Expression and Immunosuppressive Cytokine Production by Regulatory T Cells of Ulcerative Colitis Patients, Immunological Investigations (2016)
2. Autoimmune Diseases, Clinical Immunology (2022)
3. The Role of T Helper 17 and Regulatory T Cells in Tumor Microenvironment, Immunopharmacology and Immunotoxicology (2019)
4. Chimeric Antigen Receptor -T Cell Therapy: Applications and Challenges in Treatment of Allergy and Asthma, Biomedicine and Pharmacotherapy (2020)
5. Role of Regulatory T-Cells in Different Clinical Expressions of Helicobacter Pylori Infection, Archives of Medical Research (2016)
6. Microrna Signature of Regulatory T Cells in Health and Autoimmunity, Biomedicine and Pharmacotherapy (2018)
7. Immune Regulatory Network in Successful Pregnancy and Reproductive Failures, Biomedicine and Pharmacotherapy (2017)
8. Systematic Review and Meta-Analysis of the Incidence and Prevalence and 30-Year Trend of Inflammatory Bowel Diseases in Asia: A Study Protocol, BMJ Open (2019)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (3)
Laleh Sharifi (1)
Other Related Docs
9. Alteration of the Inflammatory and Anti-Inflammatory Cytokine Profiles of Peripheral Blood Mononuclear Cell in Crohn’S Disease Patients After Following Up, Iranian Journal of Public Health (2022)
10. Il-35, a Double-Edged Sword in Cancer, Journal of Cellular Biochemistry (2020)
11. The Skewed Balance Between Tregs and Th17 in Chronic Lymphocytic Leukemia, Future Oncology (2015)
12. Cancer Immunology, Encyclopedia of Infection and Immunity (2022)
13. Molecular Mechanisms of the Action of Vitamin a in Th17/Treg Axis in Multiple Sclerosis, Journal of Molecular Neuroscience (2015)
14. A Mechanistic Review on Plant-Derived Natural Compounds As Dietary Supplements for Prevention of Inflammatory Bowel Disease, Expert Review of Gastroenterology and Hepatology (2016)
15. Regulatory T Cells in Breast Cancer As a Potent Anti-Cancer Therapeutic Target, International Immunopharmacology (2020)
16. Cellular and Molecular Mechanisms of Immune Dysregulation and Autoimmunity, Cellular Immunology (2016)
17. Polyphenols and Inflammatory Bowel Disease: Natural Products With Therapeutic Effects?, Critical Reviews in Food Science and Nutrition (2024)
18. Cell Therapy in Transplantation: A Comprehensive Review of the Current Applications of Cell Therapy in Transplant Patients With the Focus on Tregs, Car Tregs, and Mesenchymal Stem Cells, International Immunopharmacology (2021)
19. Targeting Pathophysiological Changes Using Biomaterials-Based Drug Delivery Systems: A Key to Managing Inflammatory Bowel Disease, Frontiers in Pharmacology (2022)
20. The Therapeutic Potential of Regulatory T Cells: Challenges and Opportunities, Frontiers in Immunology (2021)
21. Dietary Intake of Fish, N-3 Polyunsaturated Fatty Acids, and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Observational Studies, European Journal of Nutrition (2020)
22. Targeted Gene Panel Sequencing for Early-Onset Inflammatory Bowel Disease and Chronic Diarrhea, Inflammatory Bowel Diseases (2017)
23. Exhaustion of T Lymphocytes in the Tumor Microenvironment: Significance and Effective Mechanisms, Cellular Immunology (2017)
24. Role of Rare Immune Cells in Common Variable Immunodeficiency, Pediatric Allergy and Immunology (2022)